Loading company…
Navigantis develops surgical robotics for treating neurovascular conditions.
Navigantis develops robotic systems to support physicians performing minimally invasive procedures for neurovascular conditions. The company raised USD 9.1 million in Series A funding in April 2024, led by Puma Venture Capital, with participation from Cormorant Asset Management and Mirae Asset Capital. It plans to use the proceeds to develop its VASCO robot.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in